Orsu Metals Corp (ORSUF) 0.0130 $ORSUF Orsu Metals

New Post Public Reply Private Reply Replies (0) Message Board

Jun 6, 2016 at 10:02 AM

Orsu Metals Corp (ORSUF) 0.0130 $ORSUF

Orsu Metals Corporation: Notice of Annual and Special Meeting of Shareholders and Posting of Circular
Marketwire Canada - Mon May 30, 1:45PM CDT
LONDON, UNITED KINGDOM--(Marketwired - May 30, 2016) - Orsu Metals Corporation (the "Corporation"

(TSX:OSU), the London-based base and precious metals exploration and development company, today announces that the notice of its annual and special meeting of shareholders, a form of proxy and an accompanying management information circular of the Corporation dated May 19, 2016 (the "Information Circular"

will be posted to holders of common shares of the Corporation ("Shareholders"

today. In addition, the audited consolidated financial statements of the Corporation for the financial year ended 31 December 2015 will also be posted to Shareholders who have elected to receive them in physical form.
OSU.TO: 0.03 (unch)

Orsu Metals Corporation results for the period ended March31, 2016 (Unaudited)
Marketwired - Thu May 12, 6:01AM CDT
LONDON, UNITED KINGDOM--(Marketwired - May 12, 2016) - Orsu Metals Corporation ("Orsu" or the "Company"

a London-based base and precious metals exploration and development company, listed on TSX (TSX:OSU), today reports its unaudited results for the quarter ended March 31, 2016 ("Q1 2016"

. A full Management's Discussion and Analysis of the results ("MD&A"

and Consolidated Financial Statements (Unaudited) for Q1 2016 (the "Financials"

will soon be available on the Company's profile on SEDAR (www.sedar.com) or on the Company's website (www.orsumetals.com). Copies of the MD&A and Financials can also be obtained upon request from the Company Secretary.
OSU.TO: 0.03 (unch)

Orsu Metals Corporation: Cancellation of Admission to Trading on AIM
Marketwired - Tue May 10, 7:59AM CDT
LONDON, UNITED KINGDOM--(Marketwired - May 10, 2016) - Further to the announcement dated April 11, 2016, Orsu Metals Corporation, (TSX:OSU)(AIM:OSU) today reminds shareholders that, with effect from tomorrow, the Company's shares will no longer admitted to trading on AIM. The Company's shares will continue to be traded on the Toronto Stock Exchange (TSX).
OSU.TO: 0.03 (unch)

Orsu Metals Corporation: Update on Conditional Sale of Karchiga Project
Marketwired - Thu May 05, 4:31AM CDT
LONDON, UNITED KINGDOM--(Marketwired - May 5, 2016) - Further to the announcement dated April 11, 2016, Orsu Metals Corporation, the London-based dual listed company (TSX:OSU)(AIM:OSU) today announces that it has received the deposit of $100,000 due from Karasat Trading FZE under the Sale and Purchase Agreement for the conditional sale of the Karchiga Project.
OSU.TO: 0.03 (unch)

Orsu Metals Corporation: Conditional Sale of Karchiga and Kogodai Projects and Cancellation of Admission to Trading on AIM
Marketwired - Mon Apr 11, 2:10AM CDT
Orsu Metals Corporation (AIM: OSU) (TSX: OSU) -
OSU.TO: 0.03 (unch)

Orsu Metals Corporation annual results for the year ended December 31, 2015 (Audited)
Marketwired - Wed Mar 30, 1:01AM CDT
Orsu Metals Corporation ("Orsu" or the "Company"

, the dual listed (TSX: OSU)(AIM: OSU) London-based base and precious metals exploration and development company today reports its audited annual results for the year ended December 31, 2015.
OSU.TO: 0.03 (unch)

Orsu Metals Corporation: Change of UK Registered Office
Marketwired - Tue Feb 09, 10:40AM CST
Orsu Metals Corporation ("Orsu" or the "Company"

, the dual listed (TSX: OSU)(AIM: OSU) London-based base and precious metals exploration and development company, today announces that, with immediate effect, the Company's UK registered office will be Berkeley Square House, Berkeley Square, London W1J 6BD, United Kingdom.
OSU.TO: 0.03 (unch)

Orsu Metals Corporation: Update on Akdjol-Tokhtazan Project
Marketwired - Mon Jan 25, 10:14AM CST
Orsu Metals Corporation ("Orsu" or the "Company"

, the London-based dual listed (TSX: OSU)(AIM: OSU) base and precious metals exploration and development company, today announces that it has received confirmation from the relevant Kyrgyz authorities that the licences for its Akdjol-Tokhtazan Project have been extended, expiring January 1, 2020 (the previous extension was for three years ended December 31, 2015).
OSU.TO: 0.03 (unch)

Orsu Metals Corporation: Update on Exclusivity Agreement for Potential Sale of Akdjol-Tokhtazan Project
Marketwired - Mon Jan 04, 9:55AM CST
Orsu Metals Corporation ("Orsu" or the "Company"

, the London-based dual listed (TSX: OSU)(AIM: OSU) base and precious metals exploration and development company, today announces that, further to the exclusivity agreement with David-Invest LLP, a Kyrgyz registered company, and a related company, David Way Limited, a Hong Kong registered company (together the "Potential Buyers"

announced on April 7, 2015, the Potential Buyers have not exercised their option to purchase the Akdjol-Tokhtazan Project before the deadline of December 31, 2015.
OSU.TO: 0.03 (unch)

Orsu Metals Corporation results for the period ended September 30, 2015 (Unaudited)
Marketwire Canada - Wed Nov 11, 1:00AM CST
Orsu Metals Corporation ("Orsu" or the "Company"

, the dual-listed (TSX:OSU)(AIM:OSU) London-based base and precious metals exploration and development company, today reports its unaudited results for the quarter ended September 30, 2015 ("Q3 2015"

. A full Management's Discussion and Analysis of the results ("MD&A"

and Consolidated Financial Statements (Unaudited) for Q3 2015 (the "Financials"

(TSX: OSU)(AIM: OSU), the London-based precious and base metals exploration and development company, announces the grant of 13,000,000 options to purchase common shares of no par value in the Company (each an "Option"

to the Directors and senior management of the Company as follows:
OSU.TO: 0.03 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...